Syntrio to Launch Ultra-Fast Fiber-Optic Internet in Aledo
VERNON, Texas–(BUSINESS WIRE)–#Fiber–Syntrio, a leading provider of fiber-to-the-home internet service in Texas, is excited to announce the expansion... Read more.
City of Hope Research Spotlight, February/March 2025
Research on diabetes, multiple myeloma, metastatic colorectal cancer, biomarkers for immunotherapy responses, heart health after pediatric cancer and a potential... Read more.
KBRA Assigns Preliminary Ratings to Oceanview Mortgage Trust 2025-INV2 (BVINV 2025-2)
NEW YORK–(BUSINESS WIRE)–#creditratingagency–KBRA assigns preliminary ratings to 72 classes of mortgage-backed securities from Oceanview Mortgage... Read more.
United States Roofing Shingles Market Outlook Report 2025-2030: The Rise of Smart Roofing, Focus on Durable Solutions, Increasing Re-roofing Demand – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “U.S. Roofing Shingles Market Research Report 2025-2030” report has been added to ResearchAndMarkets.com’s... Read more.
AHF Dedicates New Westside Healthcare Center and Pharmacy on Wilshire Blvd.
Ribbon-cutting Friday, May 16th – 12:30 p.m. Patient-centered model allows for utmost discretion and one-to-one care LOS ANGELES–(BUSINESS WIRE)–After... Read more.
CUPE- A Letter to Ontario Workers
TORONTO–(BUSINESS WIRE)–Dear Ontario Workers, As the president of Ontario Compensation Employees Union, a proud member of CUPE, I represent over 3600... Read more.
Feinstein Institutes 2025 Ross Prize awarded to Scripps Research’s Dr. Jeffery W. Kelly
The 12th Annual Ross Prize Symposium will be held June 4 in New York City MANHASSET, N.Y.–(BUSINESS WIRE)–The Feinstein Institutes for Medical Research... Read more.
United States Housewraps Market Outlook 2025-2030 | Energy Efficiency and Moisture Control Drive U.S. Housewraps Market Expansion – A $4.57 Billion Market by 2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “U.S. Housewraps Market – Focused Insights 2025-2030” report has been added to ResearchAndMarkets.com’s... Read more.
Incyte Announces FDA Approval of Zynyz® (retifanlimab-dlwr) Making it the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States
Zynyz® (retifanlimab-dlwr), a PD-1 inhibitor, is now approved for the treatment of advanced squamous cell carcinoma of the anal canal (SCAC) in combination with... Read more.
DDC Announces Record 2024 Growth and Strategic Bitcoin Reserve Initiative in Shareholder Letter by Founder & CEO Norma Chu
NEW YORK–(BUSINESS WIRE)–DDC Enterprise Ltd. (NYSEAM: DDC), today released its 2024 full year results alongside a Shareholder Letter from Founder, Chairwoman,... Read more.